NCT06839131View on ClinicalTrials.gov

A Clinical Study of SPH9788 Tablets in Healthy Chinese Subjects.

PHASE1RecruitingINTERVENTIONAL
Enrollment

94

Participants

Timeline

Start Date

March 2, 2025

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions
Healthy Participants
Interventions
DRUG

SPH9788

SPH9788 tablets administered orally

DRUG

Placebo

Matching placebo administered orally

Trial Locations (1)

Unknown

RECRUITING

Shanghai Mental Health Center, Shanghai

All Listed Sponsors
lead

Shanghai Pharmaceuticals Holding Co., Ltd

INDUSTRY

NCT06839131 - A Clinical Study of SPH9788 Tablets in Healthy Chinese Subjects. | Biotech Hunter | Biotech Hunter